Stay updated on P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and v3.4.1 was removed. This appears to be a maintenance/version update that does not modify study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:22:38.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision update: v3.4.1 added, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T13:34:07.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The page adds a 'Show glossary' option and updates metadata labels: 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. The previous labels were 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-29T06:40:56.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.4, replacing Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T03:48:43.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Locations section added with California as a site and revision updated to v3.3.3; HHS Vulnerability Disclosure and California Locations labels were removed.
    Difference
    0.2%
    Check dated 2025-12-24T14:49:00.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    The only change is a revision update from v3.3.1 to v3.3.2 with no changes to study content visible. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:27:51.000Z thumbnail image

Stay in the know with updates to P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page.